Addex Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:APE1 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
01 Aug 24	Sell€71,682	New Enterprise Associates, Inc.	Company		9,000	€7.96

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 19 shareholders own 67.58% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
44.6%	Addex Pharma S.A.	43,858,603	€3.4m	0%	no data
9.41%	Timothy Dyer	9,249,019	€710.4k	-39.7%	no data
3.06%	Robert Lutjens	3,005,836	€230.9k	0%	no data
2.58%	Jean-Philippe Rocher	2,541,197	€195.2k	0%	no data
2.55%	Vincent Lawton	2,507,987	€192.6k	0%	no data
1.62%	New Leaf Venture Partners, LLC	1,597,444	€122.7k	0%	0.15%
1.39%	Raymond Hill	1,365,532	€104.9k	0%	no data
0.73%	Caxton Associates LP	718,849	€55.2k	0%	no data
0.56%	UBS Asset Management AG	546,864	€42.0k	0%	no data
0.3%	Lombard Odier Asset Management (Switzerland) SA	296,761	€22.8k	0%	no data
0.18%	Morgan Stanley, Investment Banking and Brokerage Investments	180,000	€13.8k	0%	no data
0.16%	Herculis Partners SA	158,552	€12.2k	0%	0.17%
0.13%	ZKB Asset Management	124,940	€9.6k	0%	no data
0.11%	ADAR1 Capital Management, LLC	108,000	€8.3k	131%	no data
0.068%	Pictet Asset Management Limited	66,596	€5.1k	0%	no data
0.061%	BlackRock, Inc.	59,755	€4.6k	5.58%	no data
0.028%	LLB Asset Management AG	27,392	€2.1k	0%	no data
0.016%	Zürcher Kantonalbank, Investment Arm	15,792	€1.2k	0%	no data
0.0021%	Goldman Sachs Group, Investment Banking and Securities Investments	2,063	€158.6	0%	no data